EGFR and neoplasm: Targeted therapy is designed to interfere with critical biological pathways (such as RTK/RAS/MAP-Kinase pathway and I3K/Akt signaling) and block dysregulated proteins (such as EGFR and BRAF) which play essential roles in tumor formation, growth, and invasion (51).